Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Occlusal Splints for Bruxism in Implant Overdenture Patients
NCT04366869Completed
- Sponsor
- October University for Modern Sciences and Arts
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in bruxism (3 arms), sponsored by October University for Modern Sciences and Arts. Primary endpoint: Patient satisfaction questionnaire at 12 months. Started Jul 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT04366869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366869.